Jane A Gross's Net Worth
$92.6 Thousand
Who is Jane A Gross?
Jane A Gross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Aptevo Therapeutics Inc., aTYR PHARMA INC, and BriaCell Therapeutics Corp..
SEC CIK
Jane A Gross's CIK is 0001684258
Past Insider Trading and Trends
2017 was Jane A Gross's most active year for acquiring shares with 7 total transactions. Jane A Gross's most active month to acquire stocks was the month of February. 2017 was Jane A Gross's most active year for disposing of shares, totalling 10 transactions. Jane A Gross's most active month to dispose stocks was the month of February. 2020 saw Jane A Gross paying a total of $0.00 for 146,152 shares, this is the most they've acquired in one year. In 2017 Jane A Gross cashed out on 114,157 shares for a total of $45,609.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aptevo Therapeutics Inc. (APVO) Snapshot price: $0.325
SVP & Chief Scientific OfficerJane A Gross owns 109,583 units of Common Stock which is worth $35,614.48. In the year 2016 Jane A Gross acquired a total of 135,743 shares in Aptevo Therapeutics Inc., Jane also disposed a total of 29,548 shares of Aptevo Therapeutics Inc. equalling to $57,006.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +6.23% | 6.43K |
$1.57 | -$4,254.70 | 109.58K |
Feb 28 - Mar 1
| |||
Form 4
| +7.78% | 7.45K |
$3.13 | -$7,142.66 | 103.16K |
Mar 9
| |||
Form 4
| +10.56% | 9.14K |
—
|
—
| 95.71K |
Mar 1
| |||
Form 4
| +26.50% | 18.14K |
—
|
—
| 86.57K |
Feb 3
| |||
Form 4
| +69.32% | 28.02K |
$1.83 | -$18,439.08 | 68.43K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +61.10% | 24.82K |
$1.85 | -$15,800.22 | 65.43K |
Mar 1 - Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +333.87% | 12.21K |
$1.92 | -$11,370.24 | 15.87K |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
aTYR PHARMA INC (LIFE) No price found
InvestorJane A Gross owns 6,000 units of Common stock. From 2019 to 2024 Jane A Gross acquired a total of 6,000 shares in aTYR PHARMA INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BriaCell Therapeutics Corp. (BCTX) Snapshot price: $0.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||